Editorial · 2013
Review articlePublished 29 Apr 2013
Challenges and Practices in Building and Implementing Biosafety and Biosecurity Programs to Enable Basic and Translational Research with Select Agents
Department of Microbiology and Immunology, University of Louisville, KY, USA; Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases, University of Louisville, KY, USA; Center for Vaccine Research, Regional Biocontainment Laboratory, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Tulane National Primate Research Center, Regional Biosafety Laboratory, Covington, LA, USA; Division of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, LA, USA; Public Health Research Institute and UMDNJ Regional Biocontainment Laboratory, New Jersey Medical School-UMDNJ, Newark, NJ, USA; Department of Microbiology and Immunology, University of Tennessee, Memphis, TN, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Select agent research in the United States must meet federally-mandated biological surety guidelines and rules which are comprised of two main components: biosecurity and biosafety. Biosecurity is the process employed for ensuring biological agents are properly safeguarded against theft, loss, diversion, unauthorized access or use/release. Biosafety is those processes that ensure that operations with such agents are conducted in a safe, secure and reliable manner. As such, a biological surety program is generally concerned with biological agents that present high risk for adverse medical and/or agricultural consequences upon release outside of proper containment. The U.S. Regional and National Biocontainment Laboratories (RBL, NBL) represent expertise in this type of research, and are actively engaged in the development of programs to address these critical needs and federal requirements. While this comprises an ongoing activity for the RBLs, NBLs and other facilities that handle select agents as new guidelines and regulations are implemented, the present article is written with the goal of presenting a simplified yet comprehensive review of these requirements. Herein, we discuss the requirements and the various activities that the RBL/NBL programs have implemented to achieve these metrics set forth by various agencies within the U.S. Federal government.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 19 Mar 2019
Airborne Exposure Assessment of Class II, Type A2 Biosafety Cabinets (BSC) at Controlling Workplace Exposures to Volatile Fractions of Select Antineoplastic Agents
Research article · 2018
A Survey of Biosafety Practices in Clinical Laboratories Personnel from 12 Selected Areas of Karachi, Pakistan
Research article · 2015
A Survey of Biosafety Practices of Clinical Laboratory Personnel in Four Selected Clinical Laboratories
Review article · 16 Apr 2020
Aquaculture Health Management Practices in Zambia: Status, Challenges and Proposed Biosecurity Measures
More from this journal
The newest in Journal of Bioterrorism & Biodefense.
Editorial · 10 Dec 2025
Advanced Biodefense: Detection, Prevention, Preparednes
Case report · 10 Dec 2025
CRISPR: Enhancing Plant Resistance for Sustainability
Editorial · 10 Dec 2025
Adaptive Global Biodefense Against Future Threats
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Bioterrorism & Biodefense
- BylineArticles whose byline prints “Colleen B. Jonsson”
- BylineArticles whose byline prints “Kelly Stefano Cole”
- BylineArticles whose byline prints “Chad J. Roy”
- BylineArticles whose byline prints “David S. Perlin”
